RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists

Randomized controlled trials have demonstrated responses to clinical parameters, but a significant proportion of allergy patients in real-life settings would have been excluded from such studies. Therefore, real-world research is needed, and there is a growing body of information on allergen immunotherapy's long-term effectiveness and safety. Real-world evidence can be a valuable instrument to better understand the patient's journey and the effectiveness and safety of therapies. For this purpose, a registry will be used for the first time in Italy to evaluate the impact of allergen immunotherapy on several outcomes, including quality of life and disease-related effects in the pediatric and adult allergic population with a socio-economic assessment and respect to real-world health.

Authors

Institutions

Publication Details

Journal
Journal of Personalized Medicine
Published
2024-08-12
DOI
https://doi.org/10.3390/jpm14080854
Citations
4
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
1.53

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists

Giovanni Costanzo, Cristiano Caruso, Mattia Giovannini, Diego Bagnasco et al.
4 citations
Journal of Personalized Medicine
Allergic Rhinitis and Sensitization
1.53
article

RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for Allergists

Giovanni Costanzo, Cristiano Caruso, Mattia Giovannini, Diego Bagnasco, Concetta Sirena, Salvatore Barberi, Marco Caminati, Giorgio Walter Canonica, Massimo Landi, Gianenrico Senna, Cristiana Indolfi, Giorgio Ciprandi, Riccardo Castagnoli, Gian Luigi Marseglia, Michele Miraglia del Giudice, Stefania Colantuono, Mario Di Gioacchino, Enrico Marco Heffler, Giovanni Paoletti, Ilaria Baglivo, Giovanni Passalacqua, Maria Angela Tosca
article en
4 citations

Abstract

Randomized controlled trials have demonstrated responses to clinical parameters, but a significant proportion of allergy patients in real-life settings would have been excluded from such studies. Therefore, real-world research is needed, and there is a growing body of information on allergen immunotherapy's long-term effectiveness and safety. Real-world evidence can be a valuable instrument to better understand the patient's journey and the effectiveness and safety of therapies. For this purpose, a registry will be used for the first time in Italy to evaluate the impact of allergen immunotherapy on several outcomes, including quality of life and disease-related effects in the pediatric and adult allergic population with a socio-economic assessment and respect to real-world health.

Journal of Personalized MedicineVol. 14(8)
Università Cattolica del Sacro Cuore (IT), University of Verona (IT), Humanitas University (IT), University of Campania "Luigi Vanvitelli" (IT), University of Pavia (IT), Istituto Giannina Gaslini (IT), Agostino Gemelli University Polyclinic (IT), University of Chieti-Pescara (IT), Meyer Children's Hospital (IT), Casa di Cura Columbus (IT), Ospedale Policlinico San Martino (IT), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), IRCCS Humanitas Research Hospital (IT), University of Florence (IT), University of Turin (IT), University of Genoa (IT)
HAL Allergy
Openalex Percentile: Top 17%
Allergic Rhinitis and Sensitization
1.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.